{
  "ptid_time": "037_S_4028_2015-06-04",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4028/2015-06-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 11,273 mm³, 49.5% below the reference mean. With a Z-score of -1.24 (10.8th percentile), this represents mild atrophy; hippocampal volume measures 6,344 mm³, 17.4% below the reference mean. With a Z-score of -1.96 (2.5th percentile), this represents moderate atrophy; whole brain volume measures 998,465 mm³, 3.0% below the reference mean. With a Z-score of -0.37 (35.5th percentile), this represents normal volume ; entorhinal cortex volume measures 2,917 mm³, 25.1% below the reference mean. With a Z-score of -1.94 (2.6th percentile), this represents moderate atrophy; fusiform gyrus volume measures 19,085 mm³, 4.8% above the reference mean. With a Z-score of 0.54 (70.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,225 mm³, 11.2% below the reference mean. With a Z-score of -0.99 (16.0th percentile), this represents normal volume . ",
  "text_data": "Age is 67.5 years. Gender is Female. Education: 18 years. MMSE: 29.0. MoCA: 26.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.07 SUVR (normal ); Total tau: 370.60 pg/mL (moderate elevated); Phosphorylated tau: 30.90 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD), along with mild ventricular enlargement. However, whole brain volume is normal, and cognitive scores (MMSE 29, MoCA 26) are within normal limits. Biomarkers show moderately elevated T-tau and mildly elevated P-tau, but normal amyloid (AV45) and no APOE4 risk allele.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Structural changes suggest early neurodegeneration, but cognitive performance is preserved, and amyloid is normal, making AD less likely. Other causes of tauopathy should be considered.)",
  "timestamp": "2025-07-26T06:39:41.756942"
}